Genetic Discovery and Risk Prediction for Type 1 Diabetes in Individuals Without High-Risk HLA-DR3/DR4 Haplotypes
- 3 December 2024
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (2) , 202-211
Abstract
OBJECTIVE: More than 10% of patients with type 1 diabetes (T1D) do not have high-risk HLA-DR3 or -DR4 haplotypes with distinct clinical features, such as later onset and reduced insulin dependence. We aimed to identify genetic drivers of T1D in the absence of DR3/DR4 and improve prediction of T1D risk in these individuals. RESEARCH DESIGN AND METHODS: We performed T1D association and fine-mapping analyses in 12,316 non-DR3/DR4 samples. Next, we performed heterogeneity tests to examine differences in T1D risk variants in individuals without versus those with DR3/DR4 haplotypes. We further assessed genome-wide differences in gene regulatory element and biological pathway enrichments between the non-DR3/DR4 and DR3/DR4 cohorts. Finally, we developed a genetic risk score (GRS) to predict T1D in individuals without DR3/DR4 and compared with an existing T1D GRS. RESULTS: A total of 18 T1D risk variants in non-DR3/DR4 samples were identified. Risk variants at the MHC and multiple other loci genome wide had heterogeneity in effects on T1D dependent on DR3/DR4 status, and non-DR3/DR4 T1D had evidence for a greater polygenic burden. T1D-associated variants in non-DR3/DR4 were more enriched for regulatory elements and pathways involved in antigen presentation, innate immunity, and β-cells and depleted in T cells compared with DR3/DR4. A non-DR3/DR4 GRS outperformed an existing risk score GRS2 in discriminating non-DR3/DR4 T1D from no diabetes (area under the curve 0.867; P = 7.48 × 10−32) and type 2 diabetes (0.907; P = 4.94 × 10−44). CONCLUSIONS: In total, we identified heterogeneity in T1D genetic risk dependent on high-risk HLA-DR3/DR4 haplotype, which uncovers disease mechanisms and enables more accurate prediction of T1D across the HLA background.Keywords
All Related Versions
Funding Information
- Division of Diabetes, Endocrinology, and Metabolic Diseases (DK120429, DK122607)
This publication has 40 references indexed in Scilit:
- Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokinesCell Genomics, 2022
- Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosisDiabetologia, 2020
- A reference panel of 64,976 haplotypes for genotype imputationNature Genetics, 2016
- Perforin facilitates beta cell killing and regulates autoreactive CD8+ T‐cell responses to antigen in mouse models of type 1 diabetesImmunology & Cell Biology, 2015
- Partitioning heritability by functional annotation using genome-wide association summary statisticsNature Genetics, 2015
- Genetics of the HLA Region in the Prediction of Type 1 DiabetesCurrent Diabetes Reports, 2011
- Bayes factors for genome‐wide association studies: comparison withP‐valuesGenetic Epidemiology, 2008
- Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetesDiabetologia, 2008
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetesDiabetologia, 2006